Swords, R. T., Coutre, S., Maris, M. B., Zeidner, J. F., Foran, J. M., Cruz, J., . . . Savona, M. R. (2018). Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML. Blood.
シカゴスタイル引用形Swords, Ronan T., et al. "Pevonedistat, a First-in-class NEDD8-activating Enzyme Inhibitor, Combined With Azacitidine in Patients With AML." Blood 2018.
MLA引用形式Swords, Ronan T., et al. "Pevonedistat, a First-in-class NEDD8-activating Enzyme Inhibitor, Combined With Azacitidine in Patients With AML." Blood 2018.
警告: この引用は必ずしも正確ではありません.